BioGaia AB (FRA:BGLA)
€ 9.025 -0.055 (-0.61%) Market Cap: 927.89 Mil Enterprise Value: 831.44 Mil PE Ratio: 31.83 PB Ratio: 6.64 GF Score: 95/100

Q3 2020 Biogaia AB Earnings Call Transcript

Oct 23, 2020 / 07:30AM GMT
Release Date Price: €8.84 (+1.84%)
Operator

Ladies and gentlemen, welcome to the BioGaia Q3 Report 2020. Today, I'm pleased to present Isabelle Ducellier, CEO; and Alexander Kotsinas, CFO. (Operator Instructions) Speakers, please begin.

Isabelle Valerie Ghislaine Ducellier;publ;CEO;President
BioGaia AB

()-&

Thank you, and good morning, everybody. Welcome to BioGaia quarter 3 presentation. As you have already heard about our disappointing results on October 12, when we issued our profit warning, but Alex and I are going to explain you today what is behind the figures.

So to start with, we are facing a total sales decrease by 21%, which is minus 17% if you exclude the currency impact, and this is mainly due to COVID-19. The main reason is that our distributor in the world, their sales forces are mainly medical sales force visiting doctors, have not to the same extent been able to visit the doctor, the health care professional or the pharmacy. So -- and that's where in most of our markets, that's where we operate.

If you look at this per

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot